Advancing a Novel Payload AxcynDOT & Its Application in First-in-Class Anti-CLDN6-ADC
2:00 pm - Monday 8th March 2027
- Outlining the AxcynDOT payload technology to overcome drug resistance
- Design and developing AT-03, a first-in-class anti CLDN6 ADC
- Presenting key pre-clinical and clinical development insights from AT03
